The U.S. Food and Drug Administration announced a proposal to remove oral phenylephrine – a common ingredient in many popular over-the-counter decongestants – from the market, citing evidence that it ...
MONTREAL and CHARLOTTE, N.C., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) today reported financial results for the third quarter ended September 30, 2024 and ...
Milestone Pharmaceuticals is gearing up for the potential FDA approval of its CARDAMYST nasal spray for PSVT, with a decision expected by March 2025. The company’s partner, Corxel, reported positive ...